啟始時間 | 標題 | P-Investigator | 經費來源 |
2023 | Development of Precision Microbiome-Based Interventions in Chronic Hepatitis B | YEN-HSUAN NI | National Science and Technology Council |
2022 | Research Center for Epidemic Prevention Science, National Taiwan University( I ) | YEN-HSUAN NI | National Science and Technology Council |
2022 | Precision Medicine Research Center( V ) | YEN-HSUAN NI | |
2022 | 臺灣醫學會雜誌 | YEN-HSUAN NI | Ministry of Health and Welfare |
2021 | Development of Novel Anti-Allergic Probiotics by Gut Microbiota Metagenomic Analysis in Infant Cohorts | YEN-HSUAN NI | National Science and Technology Council |
2021 | 高等教育深耕計畫-核心研究群:臨床合作型計畫【兒童造血幹細胞移植前後腸道微生物基因體變化與移植物對抗宿主疾病之前瞻性研究】 | YEN-HSUAN NI | Higher Education Sprout Project |
2021 | Precision Medicine Research Center( Iv ) | YEN-HSUAN NI | National Science and Technology Council |
2021 | 精準醫學研究中心(4/5) | YEN-HSUAN NI | National Science and Technology Council |
2021 | 臺灣醫學雜誌 | YEN-HSUAN NI | Ministry of Health and Welfare |
2021 | 醫學院-深耕與國際教育推動計畫 | YEN-HSUAN NI | Higher Education Sprout Project |
2021 | 高等教育深耕計畫-特色領域研究中心【總計畫_精準醫學研究中心】 | YEN-HSUAN NI | Higher Education Sprout Project |
2020 | Development of Novel Anti-Allergic Probiotics by Gut Microbiota Metagenomic Analysis in Infant Cohorts | YEN-HSUAN NI | National Science and Technology Council |
2020 | 臺灣大學防疫科學研究中心(I) | YEN-HSUAN NI | National Science and Technology Council |
2020 | 臺灣醫學會雜誌 | YEN-HSUAN NI | Ministry of Health and Welfare |
2020 | Serosurvey of vaccine preventable diseases in Taiwan | YEN-HSUAN NI | Centers for Disease Control , R.O.C. |
2019 | Development of Novel Anti-Allergic Probiotics by Gut Microbiota Metagenomic Analysis in Infant Cohorts | YEN-HSUAN NI | National Science and Technology Council |
2019 | Analytic and Intervention Omics Platforms for Medical Microbiota to Scrutinize the Disease Association and Clinical Innovations | YEN-HSUAN NI | National Science and Technology Council |
2019 | Serosurvey of vaccine preventable diseases in Taiwan | YEN-HSUAN NI | Centers for Disease Control , R.O.C. |
2018 | Gut Microbiota Play a Critical Role in Determining the Agedependent Outcome of Hepatitis B Virus Infection | YEN-HSUAN NI | National Science and Technology Council |
2018 | The Oncofetal Rbmy Protein and Gut Microbiota Dysbiosis Facilitate the Development and Metastasis of Hepatocellular Carcinoma | YEN-HSUAN NI | National Science and Technology Council |
2018 | Development of Analytic Platforms for Microbiota and Metagenomics to Scrutinize the Disease Association and Clinical Applications: the Altheration of Gut Microbiota in Hiv-Infected Patients as an Initiative | YEN-HSUAN NI | National Science and Technology Council |
2017 | The Oncofetal Rbmy Protein and Gut Microbiota Dysbiosis Facilitate the Development and Metastasis of Hepatocellular Carcinoma | YEN-HSUAN NI | National Science and Technology Council |
2017 | Gut Microbiota Play a Critical Role in Determining the Agedependent Outcome of Hepatitis B Virus Infection | YEN-HSUAN NI | National Science and Technology Council |
2016 | The Oncofetal Rbmy Protein and Gut Microbiota Dysbiosis Facilitate the Development and Metastasis of Hepatocellular Carcinoma | YEN-HSUAN NI | National Science and Technology Council |
2015 | Intestinal Microbiota Evolution from Infancy to Early Childhood in Healthy and Diseased Status---Emphasis on Twin Study | YEN-HSUAN NI | National Science and Technology Council |
2014 | Intestinal Microbiota Evolution from Infancy to Early Childhood in Healthy and Diseased Status---Emphasis on Twin Study | YEN-HSUAN NI | National Science and Technology Council |
2014 | Faculty Development for Critical Care Medicine: Residents as Educators | YEN-HSUAN NI | National Science and Technology Council |
2013 | Intestinal Microbiota Evolution from Infancy to Early Childhood in Healthy and Diseased Status-Emphasis on Twin Study | YEN-HSUAN NI | National Science and Technology Council |
2013 | Faculty Development for Critical Care Medicine: Residents as Educators | YEN-HSUAN NI | National Science and Technology Council |
2012 | The Exploration of Genetics, Intestinal Microflora and Epithelial Cell Injury in Crohn$S Disease | YEN-HSUAN NI | National Science and Technology Council |
2012 | Faculty Development for Critical Care Medicine: Residents as Educators | YEN-HSUAN NI | National Science and Technology Council |
2011 | &Quot;Risk Factors, Genetic Polymorphism, Nature History and the Pathologic Role of Intestinal Microbiota in Pediatric Non-Alcoholic Fatty Liver Disease&Quot; | YEN-HSUAN NI | National Science and Technology Council |
2011 | &Quot;The Exploration of Genetics, Intestinal Microflora and Epithelial Cell Injury in Crohn$S Disease&Quot; | YEN-HSUAN NI | National Science and Technology Council |
2011 | Intestinal Microflora Profiles in Superbug-Infected Animal Model and the Intervention of Probiotics | YEN-HSUAN NI | National Science and Technology Council |
2010 | The Exploration of Genetics, Intestinal Microflora and Epithelial Cell Injury in Crohn's Disease | YEN-HSUAN NI | National Science and Technology Council |
2010 | Risk Factors, Genetic Polymorphism, Nature History and the Pathologic Role of Intestinal Microbiota in Pediatric Non-Alcoholic Fatty Liver Disease | YEN-HSUAN NI | National Science and Technology Council |
2009 | Risk Factors, Genetic Polymorphism, Nature History and the Pathologic Role of Intestinal Microbiota in Pediatric Non-Alcoholic Fatty Liver Disease | YEN-HSUAN NI | National Science and Technology Council |
2008 | The Immunogenicity of Hepatitis B Vaccine Booster to Prophylaxis against De Novo Hepatitis B Infection after Liver Transplantation in Children and the Follow-up on Those WHO Had Already Infected with De Novo Hepatitis B | YEN-HSUAN NI | National Science and Technology Council |
2007 | The Immunogenicity of Hepatitis B Vaccine Booster to Prophylaxis against De Novo Hepatitis B Infection after Liver Transplantation in Children and the Follow-up on Those Who Had Already Infected with De Novo Hepatitis B | YEN-HSUAN NI | National Science and Technology Council |
2006 | The Immunogenicity of Hepatitis B Vaccine Booster to Prophylaxis against De Novo Hepatitis B Infection after Liver Transplantation in Children and the Follow-up on Those Who Had Already Infected with De Novo Hepatitis B | YEN-HSUAN NI | National Science and Technology Council |
2005 | Immunogenecity of Booster Hepatitis B Vaccines in Children after Liver Transplantation | YEN-HSUAN NI | National Science and Technology Council |
2004 | To Study Hepatocyte Gene Expression in Acute Hepatitis by Hepatitis B-Recombinant Baculovirus | YEN-HSUAN NI | National Science and Technology Council |
2003 | Evaluation of Core Gene Deletion Mutant as an Antiviral Agents against Hepatitis B Virus Replication by Using Recombinant Baculovirus-infected HepG2 Cells (III) | YEN-HSUAN NI | National Science and Technology Council |
2002 | Evaluation of Core Gene Deletion Mutant as an Antiviral Agents against Hepatitis B Virus Replication by using Recombinant Baculovirus-Infected HepG2 Cells (II) | YEN-HSUAN NI | National Science and Technology Council |
2001 | Evaluation of Core Gene Deletion Mutant as an Antiviral Agents against Hepatitis B Virus Replication by Using Recombinant Baculovirus-Infected HepG2 Cells (I) | YEN-HSUAN NI | National Science and Technology Council |
2000 | Development of Liver-Specific Asailoglycoprotein-Protamine-Liposome Complex to Carry Foreign DNA As a Gene Therapy Vector | YEN-HSUAN NI | National Science and Technology Council |
1999 | Seroepidemiology of Hepatitis B Virus Infection 15 Years after the Launch of Nationwide Mass Vaccination Program | YEN-HSUAN NI | Ministry of Health and Welfare |
1999 | Primary Helicobacter pylori Infection Acquired in Childhood | YEN-HSUAN NI | National Science and Technology Council |
1998 | Protamine Sulfate May Enhance the Transfection Efficiency of Liposome-Mediated Gene Transfer to Hepatocytes---An Application to ex vivo Hepatic Gene Therapy | YEN-HSUAN NI | National Science and Technology Council |